# Re-usable Respimat® Soft MistTM Inhaler Study

> **NCT04011735** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 262 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Respimat

## Key facts

- **NCT ID:** NCT04011735
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-30
- **Primary completion:** 2020-02-13
- **Final completion:** 2020-02-13
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011735, "Re-usable Respimat® Soft MistTM Inhaler Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04011735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*